Price$86.67+2.98 (+3.55%)
01:30 PM07:45 PM
News · 26 weeks41+50%
2025-11-022026-04-26
Mix3090d
- Insider17(57%)
- SEC Filings5(17%)
- Other4(13%)
- Earnings2(7%)
- Analyst1(3%)
- Dividends1(3%)
Latest news
25 items- PRRevvity Board Declares Quarterly DividendThe Board of Directors of Revvity, Inc. (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 7, 2026 to all shareholders of record at the close of business on July 17, 2026. About Revvity At Revvity, "impossible" is inspiration, and "can't be done" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screeni
- INSIDERSEC Form 4 filed by Gonzales Anita4 - REVVITY, INC. (0000031791) (Issuer)
- PRRevvity to Present at Upcoming Investor ConferencesRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: BofA Securities 2026 Health Care Conference Wednesday, May 13, 2026 9:20 a.m. PT - Steve Willoughby, senior vice president, investor relations, ESG, risk Goldman Sachs 47th Annual Global Healthcare Conference Tuesday, June 9, 2026 8:40 a.m. ET - Prahlad Singh, president and chief executive officer Attendees will receive an update on the Company and its strategic priorities during fireside chats. Live audio webcasts will be available on the Events section of the Company's website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and w
- ANALYSTRevvity downgraded by Barclays with a new price targetBarclays downgraded Revvity from Overweight to Equal Weight and set a new price target of $95.00
- PRRevvity to Hold Earnings Call on Tuesday, May 5, 2026Revvity, Inc. (NYSE:RVTY), today announced that it will release its first quarter 2026 financial results prior to market open on Tuesday, May 5, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call. To access the call, a live audio webcast will be available on the Investors section of the Company's website. About Revvity At Revvity, "impossible" is inspiration, and "can't be done" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows
- PRRevvity Unveils its Signals BioDesign Offering to Advance Biologic Research WorkflowsScalable collaboration for biotech and pharma teams: Enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing Integrated, AI-ready biologics ecosystem: Connects design to execution through native Signals One platform integration and cloud-native infrastructure Unified molecular cloning workflows: Supports Golden Gate, Gibson assembly, restriction/ligation, primer design, and sequencing analysis in one platform Revvity, Inc. (NYSE:RVTY) announced that its Revvity Signals Software business is launching Signals BioDesignTM, a cloud-native molecular cloning solution that streamlines biologics research workflows. Built for biotech and pharma R&D tea
- INSIDERSEC Form 4 filed by Gonzales Anita4 - REVVITY, INC. (0000031791) (Issuer)
- SECSEC Form DEFA14A filed by Revvity Inc.DEFA14A - REVVITY, INC. (0000031791) (Filer)
- SECSEC Form DEF 14A filed by Revvity Inc.DEF 14A - REVVITY, INC. (0000031791) (Filer)
- INSIDEROfficer Gonzales Anita was granted 1,721 shares, increasing direct ownership by 42% to 5,799 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- SECSEC Form PRE 14A filed by Revvity Inc.PRE 14A - REVVITY, INC. (0000031791) (Filer)
- INSIDEROfficer Victor Miriame exercised 1,862 shares at a strike of $95.74 and sold $180,856 worth of shares (1,862 units at $97.13) (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDERDirector Mcmurry-Heath Michelle sold $58,356 worth of shares (600 units at $97.26), decreasing direct ownership by 12% to 4,233 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- SECSEC Form 10-K filed by Revvity Inc.10-K - REVVITY, INC. (0000031791) (Filer)
- INSIDEROfficer Victor Miriame covered exercise/tax liability with 1,031 shares, decreasing direct ownership by 5% to 18,122 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Vohra Tajinder S covered exercise/tax liability with 566 shares, decreasing direct ownership by 4% to 13,965 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Krakowiak Maxwell covered exercise/tax liability with 2,359 shares, decreasing direct ownership by 13% to 16,412 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Gonzales Anita covered exercise/tax liability with 237 shares, decreasing direct ownership by 5% to 4,078 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Singh Prahlad R. covered exercise/tax liability with 6,901 shares, decreasing direct ownership by 6% to 113,312 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Goldberg Joel S covered exercise/tax liability with 1,733 shares, decreasing direct ownership by 4% to 41,514 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- PRRevvity to Present at Upcoming Investor ConferencesRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: Raymond James 47th Annual Institutional Investors Conference Monday, March 2, 2026 7:30 a.m. ET - Max Krakowiak, senior vice president and chief financial officer TD Cowen 46th Annual Health Care Conference Tuesday, March 3, 2026 2:30 p.m. ET - Prahlad Singh, president and chief executive officer Barclays 28th Annual Global Healthcare Conference Tuesday, March 10, 2026 10:30 a.m. ET - Prahlad Singh Attendees will receive an update on the Company and its strategic priorities during fireside chats. Live audio webcasts will be available on the Events section of the Company's website. Rep
- INSIDEROfficer Vohra Tajinder S covered exercise/tax liability with 359 shares and was granted 4,448 shares, increasing direct ownership by 39% to 14,531 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Singh Prahlad R. covered exercise/tax liability with 3,421 shares, was granted 26,796 shares, exercised 25,525 shares at a strike of $92.09 and sold $2,557,859 worth of shares (25,525 units at $100.21), increasing direct ownership by 24% to 120,213 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Goldberg Joel S covered exercise/tax liability with 869 shares, was granted 6,427 shares, exercised 12,717 shares at a strike of $92.09 and sold $1,274,357 worth of shares (12,717 units at $100.21), increasing direct ownership by 15% to 43,247 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
- INSIDEROfficer Victor Miriame covered exercise/tax liability with 536 shares and was granted 5,401 shares, increasing direct ownership by 34% to 19,153 units (SEC Form 4)4 - REVVITY, INC. (0000031791) (Issuer)
RVTY FAQ
6 questionsWhere does RVTY stock trade?
Revvity Inc. (RVTY) is listed on NYSE.What sector and industry is RVTY in?
Revvity Inc. operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.Does RVTY pay a dividend?
Yes. RVTY's next ex-dividend date is 2026-07-17 with a declared cash dividend of $0.07 per share, payable 2026-08-07.What are analysts saying about RVTY?
Revvity Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight on 2026-04-14.What companies are similar to RVTY?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), BIO (Bio-Rad Laboratories Inc.). Compare RVTY side-by-side with any of them on Quantisnow.How can I track RVTY on Quantisnow?
Quantisnow aggregates Revvity Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RVTY to receive live email and push alerts on every new disclosure.